com/MeetingCoverage/DDW/14532
CHICAGO, June 3 -- A single course of interferon-based therapy, with or without ribavirin, produces long-term improvements in liver
histology in patients with hepatitis C (HCV) who completely clear the virus, researchers found
Patients who had a sustained virologic response had significant reductions in inflammation and fibrosis of the liver five or six years after receiving treatment, Mitchell Shiffman, M.D.